Mshana Stephen E, Kamugisha Erasmus, Mirambo Mariam, Chakraborty Trinad, Lyamuya Eligius F
Weill Bugando University College of Health Science Box 1464, Mwanza, Tanzania.
BMC Res Notes. 2009 Mar 26;2:49. doi: 10.1186/1756-0500-2-49.
Antimicrobial resistance is fast becoming a global concern with rapid increases in multidrug-resistant Gram negative organisms. The prevalence of extended spectrum beta-lactamase (ESBL)-producing clinical isolates increases the burden on implementing infectious disease management in low socio-economic regions. As incidence can vary widely between regions, this study was done to determine resistance patterns of Gram-negative organisms at Bugando Medical Center, a tertiary hospital in Mwanza, Tanzania.
A total of 800 clinical samples (urine, wound swab, pus, blood, aspirate, sputum etc) were processed over a period of 6 months. Gram-negative bacteria were identified using conventional in-house biochemical tests and susceptibility to common antibiotics done using disc diffusion methods. The disc approximation method was used to identify ESBL producers.
A total of 377 Gram-negative bacteria (GNB) recovered from 377 clinical specimens were analyzed of which 76.9% were Enterobacteriaceae. Among all GNB, 110/377 (29.2%) were found to be ESBL producers. Species specific ESBLs rate among Klebsiella pneumoniae, Escherichia coli, Acinetobacter spp, Proteus spp and other enterobacteria were 63.7%, 24.4%, 17.7%, 6.4% and 27.9% respectively. A statistically significant higher number of inpatients 100/283 (35.3%) compared to 10/94 (10.6%) of outpatients had ESBL-producing organisms (p = 0.000023). Rates of resistances to gentamicin, tetracycline, sulphamethaxazole/trimethoprim and ciprofloxacin were significantly higher among ESBLs isolates than non-ESBL isolates (p = 0.000001).
ESBL producing organisms are common at BMC (Bugando Medical Center) and pose a challenge to antibiotic therapy. Successful implementation of a routine detection of ESBL production is essential in designing appropriate antibiotic prescribing policies and infection control intervention programmes.
随着多重耐药革兰氏阴性菌的迅速增加,抗菌药物耐药性正迅速成为一个全球关注的问题。产超广谱β-内酰胺酶(ESBL)的临床分离株的流行增加了在社会经济水平较低地区实施传染病管理的负担。由于不同地区的发病率差异很大,本研究旨在确定坦桑尼亚姆万扎的一家三级医院布甘多医疗中心革兰氏阴性菌的耐药模式。
在6个月的时间里共处理了800份临床样本(尿液、伤口拭子、脓液、血液、抽吸物、痰液等)。使用常规的内部生化试验鉴定革兰氏阴性菌,并采用纸片扩散法检测其对常用抗生素的敏感性。采用纸片逼近法鉴定产ESBL菌。
对从377份临床标本中分离出的377株革兰氏阴性菌(GNB)进行了分析,其中76.9%为肠杆菌科细菌。在所有GNB中,发现110/377(29.2%)为产ESBL菌。肺炎克雷伯菌、大肠杆菌、不动杆菌属、变形杆菌属和其他肠杆菌中产ESBL菌的比例分别为63.7%、24.4%、17.7%、6.4%和27.9%。住院患者中产ESBL菌的比例为100/283(35.3%),显著高于门诊患者的10/94(10.6%)(p = 0.000023)。ESBL分离株对庆大霉素、四环素、磺胺甲恶唑/甲氧苄啶和环丙沙星的耐药率显著高于非ESBL分离株(p = 0.000001)。
产ESBL菌在布甘多医疗中心很常见,对抗生素治疗构成挑战。成功实施ESBL产生的常规检测对于设计适当的抗生素处方政策和感染控制干预计划至关重要。